Beleaguered Akorn Files For Bankruptcy
Pursues Chapter 11 Process After Defaulting On Term Loan
Akorn and its subsidiaries in the US have gone ahead with a Chapter 11 bankruptcy filing, paving the way for an in-court sale of the business and bringing the curtain down for now on the story of one of the hottest generic injectable properties of the last decade.